That is essential, due to the fact that the way a protein in the human body folds identifies if a pharmaceutical will be able to bind to that protein and be reliable. In other words, we need to know how these proteins fold if we desire a drug to work. Historically, this has actually been an experimental process (tech predictions). Now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're developed to do. This was an advancement almost nobody observed. But it's going to have extensive implications for treating disease. I predict that Alpha, Fold will be 98% accurate by the end of 2021.
And, of course, there will be a lot of investment chances in this area, too. Moving topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (self-driving cars). That stated, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I would not be surprised if it drew back perhaps considerably before going higher - jeff brown biotech picks. I have actually been covering bitcoin for a very long time now. Among the very first research reports I ever published was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial recommendation, I entitled my report "What's the Big Offer With Bitcoin?" That shows you where the discussion was at the time. We were mostly informing readers. However that's not the huge concern any longer. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche business. Mass, Mutual is a relied on 170-year-old institution. So think about that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
And that's a big reason I'm bullish on it this year. white house. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus offer prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These business raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I forecast 2021 will be another record year in IPOs. There are many great personal companies on the verge of striking the public markets And I have actually been dealing with a brand-new way for you to invest even before these companies go public.
This chance has been building over the last few years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to find out all the details. Go right here to reserve your spot for complimentary.
Emma Walsh here, handling editor of the Diary. Routine Diary readers know that tech isn't our normal beat (jeff brown 1 biotech). And when it concerns tech investing, we leave it to the professionals. The good news is, we have several such specialists in our Rolodex. Our coworker Jeff Brown will recognize to our long time readers. He is one of the most accomplished tech investing experts we understand (jeff brown biotech pick). In truth, he had a number of triple-digit returns in his Brownstone Research portfolios last year. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to have a look at the big photo and predict what's just around the corner.
That includes things like 5G networks, biotech, synthetic intelligence, and far more. These patterns are experiencing exponential growth and producing amazing chances for financiers. I wish to ensure all our readers are gotten ready for what's next. And with that in mind, let me draw the image of what I see being available in the next 12 months Our brand-new 5G (fifth-generation) cordless networks are a subject I have actually been covering for years now. genetic sequencer stock jeff brown. But regardless of what numerous readers might believe, this is a pattern that's simply getting going. Although the COVID-19 pandemic interfered with supply chains last year, a remarkable 250 million 5G-enabled devices were still sold.
And all of this eventually caused Apple postponing the release of the 5G-enabled i, Phone 12 by 2 months (jeff brown stock predictions 2021). Losing two months of production and sales really affects how numerous 5G gadgets are sold in the fiscal year. When you consider all of that, offering 250 million units is exceptional. More significantly, the hold-ups brought on by the pandemic developed a lot of bottled-up demand. And that need is now going to be pushed into 2021. In truth, I predict that more than 500 million 5G gadgets will be shipped in 2021 - diplomatic relations. Which's not my only 5G forecast When I've talked about 5G in the past, I have actually described its 3 different stages.
In Phase 2, 5G devices go on sale. 5G phones and other items begin to reach consumers. And in Phase Three, 5G services begin to be offered (angel investor). That's when we begin to see applications operating on 5G networks. Consider things like enormous multiplayer video games over a smart phone. That's not possible with 4G. It will be with 5G. And my second 5G prediction for 2021 is that we will start Phase 3 by this summer. This begins something of a virtuous cycle: The majority of people do not really care about the innovation. However they will care if there are exciting applications that can just be accessed with a 5G phone.
That causes more 5G apps being developed. In fact, 5G is going to open up a suite of unbelievable applications: self-driving cars and trucks, the Web of Things, robotic surgical treatment, and more. All of these innovations require 5G. The investment chances going forward will be massive. Stepping away from 5G, the next important innovation I visualize in 2021 is CRISPR genetic editing. CRISPR stands for "clustered regularly interspaced short palindromic repeat." It's a mouthful. However it's one of the most exciting developments in biotechnology. At a high level, CRISPR is a technology that can edit our genetic makeup as if it were software.
The program can crash or not function correctly. CRISPR uses a similar concept but with our genetic code. "Typos" in our genome can lead to disease. CRISPR can fix these "typos." For many years, CRISPR was mainly a niche innovation that wasn't well comprehended. And during that time, there were actually only 3 companies operating in this area. However things are changing. CRISPR is no longer simply theoretical. We're seeing real outcomes. We're treating diseases and seeing that this innovation just works. And as a result, a "second crop" of early-stage CRISPR companies is going public and providing extraordinary returns. This whole industry is successfully a greenfield chance.
There's space for numerous business to exist in this space. jeff brown biotech pick. And there will be more. That's my forecast for CRISPR in 2021. I anticipate that two or 3 more genetic modifying business will hold their IPOs. Sticking to biotechnology, we are seeing incredible things happening at the convergence of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its latest Alpha, Fold software application can accurately predict the folding of a protein based entirely on its amino acid series with 92. 4% precision. That's important due to the fact that the way a protein in the human body folds identifies if a pharmaceutical will be able to bind to that protein and work.
Historically, this has been an experimental procedure. But now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're designed to do. And here's my next prediction. I predict that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one however several drug therapies produced utilizing this innovation. This was one of those advancements that nearly nobody noticed. However it's going to have profound ramifications for curing disease. And, of course, there will be a lot of investment chances in this area, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be amazed if it drew back maybe significantly before going greater. I have actually been covering bitcoin for a long period of time now. One of the first research study reports I ever published was on bitcoin - jeff brown 2021 predictions. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anybody who followed my suggestion. However at the time of that preliminary suggestion, I entitled my report, "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time.
However nobody is asking that concern any longer. Now, we're seeing institutional money finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche enterprise. black sea. Mass, Mutual is a 150-year-old organization. So think about that. In 5 years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a big reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more perk prediction In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown deserves about $27. 5 million and claims the info depends on date as of February 2021, but we could not independently validate this claim. Offered Jeff Brown's past, he likely has a substantial net worth, however we can't hammer down an accurate figure at this moment. Brown is best known for his sage-like ability to select winning innovation stocks. He spent more than 25 years looking into technology companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience provides him an excellent perspective on the market. He's always on the hunt for brand-new chances, and he shares a lot of his finest choices in the Future Report.
That's high praise, but it's not absurdly reasoned. Brown has an excellent credibility as a stock-picker, and he successfully forecasted a few of the greatest economic events of the previous twenty years. Although he doesn't appear to release his picks to the public, the service's success is a direct indication of Brown's stock-picking expertise. No one on Wall Street gets it best whenever, but Jeff Brown's precise predictions have earned him legions of devoted fans. That states a lot about his capability. The Future Report is released by Brownstone Research, a prominent monetary research study publisher. Brownstone Research study offers a number of research services with a wide range of specializations - melania trump.
The company is also affiliated with Bonner & Partners, another well-respected research study publisher - exponential tech investor. On its website, Brownstone states its objective is to provide retail investors with professional-grade research study: "For too long, the best financial investment research has not been available to private investors. It has actually been usually booked for investment banks, hedge funds, private equity, and high-net-worth clients. jeff brown genetic sequencing stock. The mission of Brownstone Research study is to make that sort of proprietary research offered to any investors wanting to get an edge in the marketplaces. The goal is easy to deliver distinct and successful investment research study discovered nowhere else." -Brownstone Research study website excerpt from the Jeff Brown is the creator of Brownstone Research study, and he also serves as the company's Chief Investment Expert.
With Brown guiding the ship, Brownstone Research study is a powerhouse publisher with lots to provide its customers. After years of steady success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a home name throughout the majority of America. If you know even a bit about the market, you understand that he has a reputation as a King Midas of sorts. biotech stocks jeff brown. Whatever he touches turns to gold! Jeff is aware of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge job.
In reality, Brown believes S.A.V. last week. might be "the biggest trend of the 2020s, and he's not alone. Take a look at these quotes from other popular S.A.V. bulls: Elon's next huge act will be weding two cutting-edge innovations: artificial intelligence and electrical cars and trucks. Musk hopes the mix will help him establish the first fully-autonomous, self-driving vehicles ever. It's absolutely nothing except the automobile industry's Holy Grail. As you know, electric vehicles and self-driving cars and truck stocks have been substantial this year, however the Wall Street device has actually been huge on hype without much concrete result. Regardless of an extreme boost in competitors over the past few years, Brown still thinks Musk has the very best chance of putting it all together.
tech could be the magic string that ties it all together. S.A.V. stands for Shared Autonomous Lorry, and it might be the future of transportation. Generally, this innovation would allow you to lease your vehicle as an autonomous, self-driving taxi when you're not utilizing it. You simply leave the cars and truck and press a button on an app that informs the cars and truck to "sign up with the fleet." Next thing you know, you're unwinding on your couch while your automobile shuttles ride-sharers around town. Most importantly, you get to keep a hefty portion of the profits. It sounds crazy, however it might be closed than you think.